News
On the third day of the HIMSS12 conference in Las Vegas, Farzad Mostashari, MD, took to the stage in what ended up being a rousing address to a packed room of attendees. Addressing everything from the nation's progress in the past two years to the work still needing to be done, he touched on all aspects of what the industry had seen, is seeing, and will see in the years to come.
Here are seven key highlights from Mostashari's keynote speech.
Hospitals and health systems can reap significant short- and long-term benefits by proactively addressing their real estate strategies as part of the mergers and acquisitions process, says financial services firm Jones Lang LaSalle (JLL).
The Federal Trade Commission has dismissed its lawsuit against Omnicare after the long-term care pharmacy provider dropped its hostile bid to take over rival PharMerica.
As expected, the next stage of meaningful use builds on the criteria set forth in the first stage.
C. Martin Harris, MD, chief information office at the Cleveland Clinic, speaks about the importance of connecting the clinical and financial sides of healthcare.
Blue Cross Blue Shield of Nebraska is challenging the state's decision to switch insurance companies for state employees to UnitedHealthcare - a decision worth $184 million annually.
The U.S. Department of Health and Human Services has released a draft of the national plan to address Alzheimer's disease, an affliction that affected an estimated 5.4 million Americans in 2011 and is expected to affect 13.2 million by 2050.
A program that provides home visits and education for families with children living with asthma has shown to dramatically reduce hospitalizations for the condition, meanwhile saving $1.46 in hospital care for every $1 spent on prevention.
January was a record month for healthcare merger and acquisition activity with 95 deals worth a combined total of $17.2 billion being transacted, according to a recent report from Irving Levin Associates.
A new program seeks to curb healthcare expenses by educating providers to consider issues of cost and value when ordering medical tests and treatments.